| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | News |
| Series Details | 3.5.11 |
| Publication Date | 03/05/2011 |
| Content Type | News |
|
The European Medicines Agency is working with its European and international regulatory partners to monitor and evaluate the possible risk of radioactive contamination of medicines manufactured in Japan following the radiation leak from the Fukushima Daiichi nuclear power plant. |
|
| Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/05/news_detail_001251.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1 |
| Subject Categories | Health |
| Countries / Regions | Europe, Japan |
